Boothbay Fund Management’s Nurix Therapeutics NRIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-69,134
Closed -$1.55M 1589
2024
Q3
$1.55M Sell
69,134
-47,994
-41% -$1.08M 0.04% 503
2024
Q2
$2.44M Buy
117,128
+37,358
+47% +$780K 0.06% 366
2024
Q1
$1.17M Buy
+79,770
New +$1.17M 0.02% 595